Protect Pharmaceutical Corporation Financial Ratios — PRTT

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	- -	-309.74	-215.39	-3,106.94	77,454.78	-249,691.16	-1,191,628.57	- -
Return on Capital (%)	- -	- -	- -	- -	- -	-5.12	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.88
Net Debt/EBITDA	- -	- -	0.02	- -	0.03	0.02	- -	- -	-0.88
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.88
Net Debt/EBIT	- -	- -	0.02	- -	0.03	0.02	- -	- -	-0.88
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-16
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-16
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-16
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	- -	- -	-1,629.28	-1,037,926.63	-1,346,953.01	-1,735,932.47	-133,496,214.29	- -	- -
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-1.07
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-70.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-1.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt to Equity	- -	- -	76.74	0.15	0.11	0.41	0.01	- -	-70.41
Net Debt/Capital (%)	- -	- -	0.26	0.01	0.01	0.01	- -	- -	-1.07
EBITDA	- -	-7	-1	-1	- -	- -	- -	- -	- -
EBITDA-CapEx	- -	-7	-1	-1	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	-7	-1	-1	- -	- -	- -	- -	- -

Liquidity (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Cash Ratio	- -	- -	0.04	- -	- -	- -	- -	- -	- -
Current Ratio	- -	- -	0.95	- -	- -	- -	- -	- -	- -
Quick Ratio	- -	- -	0.04	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	- -	-0.97	-0.04	- -	- -	-0.16	-0.23	- -
Common Equity/Total Assets	- -	- -	-1,629.28	-1,037,926.63	-1,346,953.01	-1,735,932.47	-133,496,214.29	- -	- -
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-1.07
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-70.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-1.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	- -	- -	-89.43	-3.7	-0.03	-0.15	-17.72	-67.97	- -
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	- -	-32.69	-17,826.11	-20,022.49	-24,774.93	-1,901,431.89	- -	- -

Working Capital (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Market Capitalization	- -	- -	- -	- -	- -	4	- -	1	1
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	4	- -	1	1
Total Capital	-1	-8	-8	-9	-9	-9	-9	-9	-9
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-1.07
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.1
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	137.31
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	137.31
Diluted Market Cap	- -	- -	- -	- -	- -	4	- -	1	1
Diluted Enterprise Value	- -	- -	- -	- -	- -	4	- -	1	1
EV per Share	0.25	1.15	359.49	0.08	0.03	79.99	0.6	1	0.89
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-7	-1	-1	- -	- -	- -	- -	- -
TTM Operating Income	- -	-7	-1	-1	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Price/Free Cash Flow	- -	- -	-0.03	-0.2	-12.45	-24,155.08	-14.9	-78.5	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	4	- -	1	1
Low Price	0.25	0.25	0.36	0.1	0.05	0.05	0.6	0.6	0.75
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	9.44	- -	- -	- -
Price/Earnings Average	-3.89	- -	-0.05	-0.01	-0.13	0.2	-1.15	-17.95	-9.22
Price/Earnings High	-5.4	-0.01	-0.06	-0.03	-0.28	9.44	-55.67	-35.98	-13.6
Price/Earnings Low	-3.86	- -	-0.02	-0.01	-0.09	0.01	-0.42	-15.99	-6.8
Price/Book Value	-0.01	-0.01	- -	- -	- -	-0.5	-0.03	-0.12	-0.09
Price/Book Value Average	-0.01	- -	- -	- -	- -	-0.01	-0.08	-0.08	-0.12
Price/Book Value High	-0.02	-0.01	-0.01	- -	- -	-0.5	-3.79	-0.16	-0.18
Price/Book Value Low	-0.01	- -	- -	- -	- -	- -	-0.03	-0.07	-0.09
Price/Tangible Book Value	-1.58	-0.1	-0.55	-0.01	- -	-35.74	-2.64	-53.36	-6.2
Price/Tangible Book Value Average	-1.6	-0.07	-1.41	-0.01	-0.01	-0.76	-7.27	-35.93	-7.88
Price/Tangible Book Value High	-2.22	-0.1	-1.75	-0.03	-0.01	-35.74	-352.16	-72.03	-11.62
Price/Tangible Book Value Low	-1.58	-0.02	-0.55	-0.01	- -	-0.02	-2.64	-32.02	-5.81
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-0.03	-0.2	-12.45	-24,155.08	-14.9	-78.5	- -
Price/Cash Flow Average	- -	- -	-0.08	-0.34	-17.63	-516.77	-40.99	-52.87	- -
Price/Cash Flow High	- -	- -	-0.1	-0.75	-37.35	-24,155.08	-1,986.72	-105.98	- -
Price/Cash Flow Low	- -	- -	-0.03	-0.2	-12.45	-15.1	-14.9	-47.1	- -
Price/Free Cash Flow Average	- -	- -	-0.08	-0.34	-17.63	-516.77	-40.99	-52.87	- -
Price/Free Cash Flow High	- -	- -	-0.1	-0.75	-37.35	-24,155.08	-1,986.72	-105.98	- -
Price/Free Cash Flow Low	- -	- -	-0.03	-0.2	-12.45	-15.1	-14.9	-47.1	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-3.89	- -	-0.01	-0.01	-0.1	-2.98	-24.31	-17.95	-10.67
EV/EBITDA High	-5.4	-0.01	-0.02	-0.03	-0.25	-140.15	-1,178.06	-35.98	-15.32
EV/EBITDA Low	-3.86	- -	- -	-0.01	-0.06	-0.07	-8.84	-15.99	-8.1
EV/EBIT Average	-3.89	- -	-0.01	-0.01	-0.1	-2.98	-24.31	-17.95	-10.67
EV/EBIT High	-5.4	-0.01	-0.02	-0.03	-0.25	-140.15	-1,178.06	-35.98	-15.32
EV/EBIT Low	-3.86	- -	- -	-0.01	-0.06	-0.07	-8.84	-15.99	-8.1
Last Price	0.25	1.15	0.36	0.1	0.05	80	0.6	1	0.8
High Price	0.35	1.15	1.15	0.36	0.15	80	80	1.35	1.5
Enterprise Value Average	- -	- -	- -	- -	- -	- -	1	1	1
Enterprise Value High	- -	- -	- -	- -	- -	4	35	2	2
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	1	1

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	1	1	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.06	-172.65	-32.73	-12.44	-0.54	-0.57	-0.07	-0.04	-0.1
Operating Income per Share	-0.06	-172.65	-32.73	-12.44	-0.54	-0.57	-0.07	-0.04	-0.1
Basic EPS, GAAP	-0.06	-172.65	-18.14	-12.44	-0.54	8.48	-1.44	-0.04	-0.11
Basic EPS from Cont Ops	-0.06	-172.65	-18.14	-12.44	-0.54	8.48	-1.44	-0.04	-0.11
Diluted EPS, GAAP	-0.06	-172.65	-18.14	-12.44	-0.54	8.48	-1.44	-0.04	-0.1
Diluted EPS from Cont Ops	-0.06	-172.65	-18.14	-12.44	-0.54	8.48	-1.44	-0.04	-0.1
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	-11.07	-0.48	- -	- -	-0.04	-0.01	- -
Free Cash Flow per Basic Share	- -	- -	-11.07	-0.48	- -	- -	-0.04	-0.01	- -
Cash & Equivalents per Share	- -	- -	0.51	0.02	0.02	0.01	- -	- -	- -
Book Value per Share	-18.3	-186.31	-190.87	-200.26	-205.79	-161.24	-21.13	-8.45	-8.56
Tangible Book Value per Share	-0.16	-11.28	-0.66	-12.95	-13.35	-2.24	-0.23	-0.02	-0.13

Protect Pharmaceutical Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)